Old Web
English
Sign In
Acemap
>
authorDetail
>
Kanwal Jit Kaur
Kanwal Jit Kaur
Yahoo!
Medicine
Pharmacology
Bioequivalence
Bioavailability
Rifampicin
7
Papers
154
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
In Vivo Dissolution: Predominant Factor Affecting the Bioavailability of Rifampicin in its Solid Oral Dosage Forms
2008
Clinical Research and Regulatory Affairs
Yasvanth Ashokraj
Kanwal Jit Kaur
Singh I
Kohli G
Shantaram R Bhade
Manthena V. Varma
Shrutidevi Agrawal
Ramesh Panchagnula
Show All
Source
Cite
Save
Citations (6)
Feasibility studies on division of fixed dose combinations of anti-tubercular drugs: an improvement in the tuberculosis therapy.
2006
Journal of Clinical Pharmacy and Therapeutics
Yasvanth Ashokraj
Kohli G
Kanwal Jit Kaur
Shantaram R Bhade
Manthena V. S. Varma
Mahua Sarkar
Namita Kapoor
Singh I
Sateesh Kandavilli
Ramesh Panchagnula
Show All
Source
Cite
Save
Citations (0)
Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels
2004
International Journal of Pharmaceutics
Shrutidevi Agrawal
Singh I
Kanwal Jit Kaur
Shantaram R Bhade
Chaman Lal Kaul
Ramesh Panchagnula
Show All
Source
Cite
Save
Citations (55)
Bioequivalence trials of rifampicin containing formulations: extrinsic and intrinsic factors in the absorption of rifampicin.
2004
Pharmacological Research
Shrutidevi Agrawal
Singh I
Kanwal Jit Kaur
Shantaram R Bhade
Chaman Lal Kaul
Ramesh Panchagnula
Show All
Source
Cite
Save
Citations (23)
Assessment of bioequivalence of rifampicin, isoniazid and pyrazinamide in a four drug fixed dose combination with separate formulations at the same dose levels.
2002
International Journal of Pharmaceutics
Shrutidevi Agrawal
Kanwal Jit Kaur
Singh I
Shantaram R Bhade
Chaman Lal Kaul
Ramesh Panchagnula
Show All
Source
Cite
Save
Citations (43)
1